Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Reata Pharmaceuticals presents new inhibitors of NO production

July 17, 2012

RNAi screen identifies targets for diseases involving protein misfolding

Jan. 13, 2012

Celtaxsys obtains anti-inflammatory drug from Estrellita Pharmaceuticals

Jan. 12, 2012

Novel anti-inflammatory agents discovered in U.K.

Jan. 11, 2012

Novel inhibitors of cytochrome P450 enzymes synthesized by Angion Biomedica

Jan. 5, 2012

Lilly withdraws Xigris worldwide following PROWESS-SHOCK study

Oct. 26, 2011

Karolinska Institutet presents novel series of selenium-containing antioxidants

May 6, 2011

Phase I trial to assess MLN-9708 in relapsed/refractory light chain amyloidosis under way

March 28, 2011

Roskamp Institute obtains IRB approval for study of RCP-006 in humans

March 4, 2011

AM-095 displays antifibrotic activity in vivo

Jan. 13, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...